CAS Medical Systems, Inc. (CASM) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS

CAS Medical Systems, Inc. (NASDAQ:CASM) released its quarterly earnings results on Tuesday, August 8th. The medical technology company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.02, MarketWatch Earnings reports. The business had revenue of $4.57 million for the quarter, compared to analysts’ expectations of $5.41 million.

Shares of CAS Medical Systems (NASDAQ:CASM) traded down 3.03% during mid-day trading on Friday, hitting $0.96. 12,450 shares of the stock traded hands. The stock’s market cap is $26.24 million. CAS Medical Systems has a 52 week low of $0.80 and a 52 week high of $1.94. The firm’s 50-day moving average is $1.12 and its 200-day moving average is $1.24.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Rincon Hill News and is the sole property of of Rincon Hill News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at

A hedge fund recently bought a new stake in CAS Medical Systems stock. Stonepine Capital Management LLC bought a new position in shares of CAS Medical Systems, Inc. (NASDAQ:CASM) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 900,366 shares of the medical technology company’s stock, valued at approximately $1,044,000. CAS Medical Systems comprises approximately 0.6% of Stonepine Capital Management LLC’s holdings, making the stock its 23rd largest position. Stonepine Capital Management LLC owned approximately 3.29% of CAS Medical Systems as of its most recent filing with the SEC. 26.71% of the stock is currently owned by institutional investors and hedge funds.

CAS Medical Systems Company Profile

CAS Medical Systems, Inc is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories.

Earnings History for CAS Medical Systems (NASDAQ:CASM)

Receive News & Ratings for CAS Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems Inc. and related companies with our FREE daily email newsletter.


Latest News

Leave a Reply

© 2006-2017 Rincon Hill News.